Hemgenix has actually been offered ‘conditional authorisation’. Consequently the eu Medicines Company made a decision that the main advantages of Hemgenix are greater than its threats, but the organization will have to provide more proof immediately after authorisation. a panel of 3 of medical specialists with expertise in diagnosing and man